Diasome Pharmaceuticals
About:
Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.
Website: https://www.diasome.com/
Twitter/X: diasome
Top Investors: Medicxi, JDRF T1D Fund, Quaker BioVentures, McDonald Partners, Devon Park BioVentures
Description:
Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals was founded in 2004 and is based in Conshohocken, Pennsylvania.
$92M
$1M to $10M
Cleveland, Ohio, United States
2004-01-01
info(AT)diasome.com
Robert Geho, W. Blair Geho
1-10
2023-06-30
Private
© 2025 bioDAO.ai